Stanford's 37K AI agents analyzed 57K clinical trials as a 'virtual biotech'
james_y_zou · x · 2026-09-25
- Stanford Biohub investigator James Zou built a "virtual biotech": 37,000 AI agents collaboratively analyzed 57,000 clinical trials to find clues to what makes drugs succeed (NYT coverage).
- The project grew from a 2024 collaboration with John Pak, where an agent team redesigned part of a Covid-19 vaccine and produced dozens of novel proteins that binding tests validated.
- The team frames the agents as AI "co-scientists" that could accelerate drug research for conditions like cancer.
More from AGI Musings
- Pedro Domingos: three reasons we're still far from AGI, no robotics ChatGPT moment in sight — pmddomingos · 2026-09-25
- Block exec: staff cuts were a "forcing function" to push AI tool adoption — rohanpaul_ai · 2026-09-25
- Block exec says staff cuts were a 'forcing function' to push AI tool adoption — rohanpaul_ai · 2026-09-25
- Fixing Claude's writing style seen as key to countering gradual disempowerment — aidan_mclau · 2026-09-25
- Investor: AI demos are dying — show me your data and your model instead — yenkel · 2026-09-25
- Dev pushes back on AI misinformation: frontier models all depend on prompting, real gap is safety controls — gerardsans · 2026-09-25